Literature DB >> 2717290

Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis.

S Koletzko1, D A Stringer, G J Cleghorn, P R Durie.   

Abstract

The efficacy, adverse reactions, and long-term effects of intestinal lavage treatment with a balanced electrolyte solution (Golytely) was evaluated in patients with cystic fibrosis and distal intestinal obstruction syndrome. Twenty-two patients with cystic fibrosis (mean age 21.8 years, range 14 to 34 years, 15 boys or men) who sought medical attention because of abdominal pain and a mass in the right iliac fossa received Golytely, 5.6 +/- 1.9 L (mean +/- 1 SD), either orally (n = 14) or via nasogastric tube (n = 8) during 5.6 +/- 2.4 hours. No serious side effects occurred. Serum electrolyte values remained within normal limits. Body weight did not change significantly. Minor adverse reactions included bloating (n = 12), nausea (n = 8), vomiting (n = 1), and chills (n = 3). All but one patient reported impressive relief of symptoms and remained pain free for an average of 3 months (range 1 to 19 months). Symptoms of abdominal pain and radiologic signs of fecal impaction assessed before and after lavage both decreased significantly (P less than .0001). During follow-up (mean 15.2 months, range 4 to 26 months), 11 patients required a total of 38 (range one to nine) additional doses of Golytely. Seven patients drank the solution at home (21 treatments); only two patients chose a nasogastric tube. In ten patients with symptoms of recurrent distal intestinal obstruction syndrome prior to institution of therapy, duration of hospitalization was significantly reduced by this treatment (5.1 +/- 7.6 v 2.3 +/- 6.3 hospital days per annum, P less than .02).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2717290

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

Review 1.  Gastrointestinal complications in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

Review 2.  Abdominal pain in cystic fibrosis.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1995       Impact factor: 5.344

3.  Hypoglycaemia and Golytely in distal intestinal obstruction syndrome.

Authors:  A Shah; S Madge; R Dinwiddie; P Habibi
Journal:  J R Soc Med       Date:  1994-02       Impact factor: 5.344

4.  Appendicitis in cystic fibrosis.

Authors:  M D Shields; H Levison; J J Reisman; P R Durie; G J Canny
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

5.  Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Authors:  Moran Lavie; Tzipora Manovitz; Daphna Vilozni; Sarina Levy-Mendelovich; Ifat Sarouk; Ilana Weintraubv; David Shoseyov; Malena Cohen-Cymberknoh; Joseph Rivlin; Ori Efrati
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Treatment of Gastrointestinal Problems in Cystic Fibrosis.

Authors:  Maria R. Mascarenhas
Journal:  Curr Treat Options Gastroenterol       Date:  2003-10

7.  Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation.

Authors:  Jonathan R Morton; Nabila Ansari; Allan R Glanville; Alan P Meagher; Reginald V N Lord
Journal:  J Gastrointest Surg       Date:  2009-05-22       Impact factor: 3.452

8.  Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.

Authors:  Peter R Durie; Geraldine Kent; M James Phillips; Cameron A Ackerley
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.